Search

everythinglearnresearchcommunity

for

Search:↓

The new scalp treatment preserves hair color, reduces hair loss, and maintains hair strength.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Cancer myths can harm treatment and prevention efforts.

Topical products, especially specific shampoos, are effective in treating androgenetic alopecia by delivering active ingredients to hair follicles and improving hair quality.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

The document concludes that hair loss has many causes and treatments vary, including medication for pattern baldness and addressing underlying issues for other types.

The combined treatment improved tendon healing strength over time.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Platelet Rich Fibrin improves healing and reduces acne scars by slowly releasing growth factors.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Microneedle made of iron oxide and PVA helps hair regrowth in alopecia treatment.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.